subunit-selective

DQP 1105 是一种高效非竞争性NMDA 受体拮抗剂。DQP-1105 抑制含有 GluN2C (IC50:7.0 Μm) 和 GluN2D (IC50:2.7 Μm) 的受体 。 IC50值至少比重组 GluN2B-、GluN2A-、GluA1- 或 GluK2 受体低 50 倍。

CSN5i-3 是一种有效的、选择性的、可口服的 CSN 复合物蛋白水解亚基 CSN5 抑制剂，抑制 CSN 催化的 Cul1 deneddylation IC50 值为 5.8 nM，CSN5i-3 对多种癌细胞具有杀伤作用，可作为抗癌药物。[2]

Thiacloprid 属于氯烟碱类杀虫剂，主要用于防治蔬菜和果园中的蚜虫。它会破坏 DNA 的稳定性，通过疏水或氢相互作用，结合到小沟槽中，改变 DNA 的结构和稳定性。

Ro 25-6981 是一种有效的选择性活性依赖性 NMDA 受体阻滞剂，含有 NR2B 亚基，对克隆受体亚基组合 NR1C NR2B 和 NR1C NR2A 的 IC50 分别为 0.009 和 52 μM。 Ro 25-6981 可用于帕金森病的研究。

Loreclezole 是一种选择性 GABAA 受体调节剂，可作为含有 β2 或 β3 亚基的受体的正变构调节剂，有抗癫痫作用。

AZD-4573 is a selective and short-acting inhibitor of the serine threonine cyclin-dependent kinase 9, the catalytic subunit of the RNA polymerase II elongation factor positive transcription elongation factor b. It also has a potential antineoplastic activ

Ro 25-6981 Maleate 是一种具有选择性的 NR2B 亚基特异性 NMDA 受体 拮抗剂，具有抗惊厥抗抑郁活性，可用于研究帕金森和癫痫等神经系统疾病。

ILS-920 is a Rapamycin analog characterized by diminished immunosuppressive effects but remarkable neuroprotective properties. It exhibits selective binding affinity towards the immunophilin FKBP52 as well as the β1-subunit of L-type voltage-gated calcium channels (VGCC). ILS-920 displays a notable 200-fold preference for FKBP52 over FKBP12.

CIQ 是亚基选择性NMDA 受体增强剂，可作用于NR2C 或NR2D 亚基。

Helenalin is a selective inhibitor of transcription factor NF-κB by direct targeting of p65. It is an anti-inflammatory sesquiterpene lactone compound with alkylating activity. Through its ability to target the cysteine sulfhydryl groups in the p65 subunit of NF-κB, helenalin effectively inhibits its DNA binding.

NFPS exerts neuroprotection via glyR alpha1 subunit in the rat model of transient focal cerebral ischaemia and reperfusion. NFPS is a selective and non-competitive glycine transporter-1 (GlyT1) inhibitor (IC50s: 2.8 nM and 9.8 nM for hGlyT1 and rGlyT1, respectively).

PR-924 is a selective inhibitor of tripeptide epoxyketone immunoproteasome subunit LMP-7 (IC50: 22 nM). PR-924 inhibits growth and triggers apoptosis in multiple myeloma (MM) cells. PR-924 has antitumor activities. PR-924 covalently modifies proteasomal N-terminal threonine active sites.

Rpn11-IN-1 is an effective and selective inhibitor of proteasome subunit Rpn11 (IC50: 390 nM).

UBP 302 is an effective and selective GLUK5-subunit-containing kainate receptor antagonist (apparent Kd=402 nM) and displays very little affinity on GluK2 kainate receptors.

Immunoproteasome activator 1 (compound A) 作为一种高选择性的免疫蛋白酶体激活剂，能显著地促进MHC-I结合肽的呈递，增幅达到超过100倍。该化合物通过与蛋白酶体的结构亚单位PSMA1结合，并进一步促使蛋白酶体激活物PA28α β (PSME1 PSME2) 与免疫蛋白酶体的有效结合，从而发挥其作用。

α5-GABAA receptor modulator 1 (Compound A-4) 是一种针对 a5 亚基的GABAA受体沉默变构调节剂 (SAM)，适用于中枢神经系统 (CNS) 疾病的研究。

NS11394 是可口服GABAA 的阳性变构调节剂 (PAM)，Ki 值为 0.5 nM。它对GABAA 的选择性依次为 α5、α3、α2 和α1 受体，具有抗炎和抗焦虑活性。

Sephin1 (IFB-088) 是 GADD34 (PPP1R15A) 的选择性抑制剂，这是一种应激诱导的蛋白磷酸酶 1 复合物调节亚基，可将 eIF2α 去磷酸化。

BMS 195614 (BMS614)是一种选择性的RARα拮抗剂。BMS 195614可以与RARα亚基结合。

σ receptor agonist and NR2B subunit-selective NMDA receptor antagonist

pdTp is a highly selective, small-molecule miRNA regulatory complex RISC subunit SND1 inhibitor.

Ro 25-6981 HCl is an effective and selective NMDA glutamate receptors containing the NR2B subunit antagonist.

UBP714 is a derivative of the NMDA receptor negative allosteric modulator UBP608. It also enhanced NMDAR mediated field EPSPs in the CA1 region of the hippocampus. UBP714 is a novel template for the development of potent and subunit selective NMDAR potent

Dezapelisib is an orally bioavailable, selective inhibitor of the delta isoform of the 110 kDa catalytic subunit of class I phosphoinositide-3 kinases (PI3K). INCB040093 prevents both the production of the second messenger phosphatidylinositol-3,4,5-trisp